- Wilson DP, Jacobson TA, Jones PH, et al. Use of lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2019;13(3):374–392. doi:10.1016/j.jacl.2019.04.010.
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213–S256. doi:10.1542/peds.2009-2107C.
- Sturm AC, Knowles JW, Gidding SS, et al. Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel. J Am Coll Cardiol. 2018;72(6):662–680. doi:10.1016/j.jacc.2018.05.044.
- McNeal CJ, Peterson AL, et al. Lipoprotein (a) in youth. 2020 Feb 9. In: Feingold KR, Anawalt B, Boyce A, eds. Endotext [Internet]. South Dartmouth, MA: MDText.com; 2020.
- Ward NC, Kostner KM, Sullivan DR, Nestel P, Watts GF. Molecular, population, and clinical aspects of lipoprotein (a): a bridge too far? J Clin Med. 2019;8(12):2073. doi:10.3390/jcm8122073.
- Wang XL, Wilcken DE, Dudman NP. Early expression of the apolipoprotein (a) gene: relationships between infants’ and their parents’ serum apolipoprotein (a) levels. Pediatrics. 1992;89(3):401–406.
- Rifai N, Heiss G, Doetsch K. Lipoprotein(a) at birth, in blacks and whites. Atherosclerosis. 1992;92(2-3):123–129. doi:10.1016/0021-9150(92)90271-H.
- Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein [a] gene accounts for greater than 90% of the variation in plasma lipoprotein[a] concentrations. J Clin Invest. 1992;90(1):52–60. doi:10.1172/JCI115855.
- Taylor A, Wang D, Patel K, et al. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet. 2010;77(6):572–580. doi:10.1111/j.1399-0004.2009.01356.x.
- Lombardi MP, Redeker EJ, van Gent DH, Smeele KL, Weerdesteijn R, Mannens MM. Molecular genetic testing for familial hypercholesterolemia in the Netherlands: a stepwise screening strategy enhances the mutation detection rate. Genet Test. 2006;10(2):77–84. doi:10.1089/gte.2006.10.77.
- van der Graaf A, Avis HJ, Kusters DM, et al. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children. Circulation. 2011;123(11):1167–1173. doi:10.1161/CIRCULATIONAHA.110.979450.
- Khera AV, Won HH, Peloso GM, et al. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardio. 2016;67(22):2578–2589. doi:10.1016/j.jacc.2016.03.520.
- Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr. 2004;145(4):427–452. doi:10.1016/j.jpeds.2004.06.042.
- Järvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes. 2002;51(2):493–498. doi:10.2337/diabetes.51.2.493.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3